Clinical Trials Logo

Insulin Sensitivity clinical trials

View clinical trials related to Insulin Sensitivity.

Filter by:

NCT ID: NCT01847456 Completed - Insulin Sensitivity Clinical Trials

Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity

Start date: April 2013
Phase: N/A
Study type: Interventional

The researchers will investigate if brain insulin action influences peripheral insulin sensitivity in healthy humans.

NCT ID: NCT01804738 Completed - Hyperglycemia Clinical Trials

Investigating Inter-individual Variability in Glycemic and Insulin Responses

Start date: March 2013
Phase: N/A
Study type: Interventional

This study aims to test the following hypothesis in healthy lean young men: - There are differences in glycemic response (GR) and insulin response (IR) between Chinese, Malay and Asian-Indian - There are differences in GI values to the same food between ethnic groups - There are ethnic differences postprandial GR and IR for high vs low GI foods - Mastication, salivary amylase activity, gastric emptying rate and gut microbiota composition influences inter-individual glycemic and insulinemic variability - Ethnic differences in mastication, salivary amylase activity, gastric emptying rate and gut microbiota composition determines the inter-ethnic glycemic and insulinemic variability

NCT ID: NCT01802541 Completed - Type 2 Diabetes Clinical Trials

Effect of Diacylglycerol Oil on Risk Factors of Type 2 Diabetes and Complicating Disease, and Mechanism

Start date: n/a
Phase: N/A
Study type: Interventional

Diacylglycerol oil has been shown to lower postprandial and fasting serum triacylglycerol levels and reduce body fat. The investigators hypothesize that replacing dietary fat with diacylglycerol oil reduces excess body fat in type 2 diabetic patients and that diacylglycerol oil has a beneficial effect on cardiovascular risk factors in Chinese type 2 diabetic patients.

NCT ID: NCT01791114 Completed - Obesity Clinical Trials

The Effect of Brown Adipose Tissue Activation on Insulin Sensitivity in Humans

Start date: January 2012
Phase: N/A
Study type: Interventional

Recent findings document the presence of active brown adipose tissue (BAT) in humans. Cold exposure via adrenergic stimulation activates BAT, which combusts significant amounts of blood glucose and free fatty acid (FFA) to produce heat. Animal studies suggest that BAT activation improves insulin sensitivity. However, the effect of cold-induced BAT activation on insulin sensitivity and glucose kinetics in humans remains unknown. The investigators' central hypothesis is that cold-induced BAT activation increases whole body insulin sensitivity in humans via augmented plasma glucose and FFA clearance. The specific aims of this study are to define the effects of prolonged (8h) cold exposure BAT activation on: insulin sensitivity (Aim 1); lipolysis and plasma glucose and FFA kinetics (Aim 2); on thermoregulation (Aim 3). Moreover, the investigators plan to investigate for alternative ways, which can activate BAT including cold water ingestion, a single meal ingestion, and a single bout of moderate intensity exercise (Aim 4). For the cold exposure study, subjects will complete 3 trials: a) 8hrs of cold exposure at their individually determined shivering threshold; b) 8hrs of cold exposure at their individually determined shivering threshold plus propranolol; c) 8hrs in thermoneutral conditions (26 - 28°C). For the rest of the arms of subjects will complete two trials: cold or tepid water ingestion, a single meal ingestion or no food ingestion, and a single bout of moderate intensity exercise or no exercise.To study the above aims, the investigators will use positron emission tomography - computed tomography, hyperinsulinemic euglycemic clamp, infusion of stable isotopes, and tissue biopsies. The findings will illuminate the role of BAT on plasma substrate regulation and insulin sensitivity and may aid in the development of lifestyle recommendations and pharmacotherapy for the prevention and treatment of diabetes and insulin resistance.

NCT ID: NCT01786941 Completed - Insulin Sensitivity Clinical Trials

Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes

BCAAM-PD
Start date: June 2012
Phase: N/A
Study type: Interventional

Elevated circulating levels of certain amino acids (the building blocks of protein) are strongly associated with insulin resistance. This study will investigate the metabolism of these amino acids in individuals with normal glucose metabolism compared to overweight or obese pre-diabetic individuals. The purpose of this study is to determine how elevated levels of the branched-chain amino acids may contribute to the development of insulin resistance and ultimately diabetes. An additional purpose is to determine whether exercise or gastric bypass (GBP) surgery intervention can correct aberrations in branched-chain amino acid metabolism as insulin sensitivity improves. This information will be used to further our understanding of the development of insulin resistance and type 2 diabetes in at-risk populations and potentially improve clinical treatment of such conditions.

NCT ID: NCT01785134 Completed - Obesity Clinical Trials

Effects of Different Surgical Methods to Treat Obesity

DEOSH
Start date: May 2006
Phase: N/A
Study type: Interventional

Obese patients have an increased risk for developing severe metabolic disorders. This risk can only partly be reduced by weight reduction. The investigators have in a pilot study investigated if removal of abdominal fat (visceral) in addition to weight loss has additional beneficial effects on the metabolic profile and weight loss. This study aims to further investigate if removal of abdominal fat (major omentum) leads to beneficial metabolic effects.

NCT ID: NCT01774084 Completed - Insulin Sensitivity Clinical Trials

Insulin Sensitivity and Beta Cell Function After Carbohydrate Loading in Hip Replacement Surgery

Start date: January 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether preload of carbohydrate or water before elective hip replacement improve insulin sensitivity and or beta cell function in human.

NCT ID: NCT01766557 Completed - Insulin Sensitivity Clinical Trials

Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome.

PCOS
Start date: August 2010
Phase: N/A
Study type: Interventional

The objective of our study is to determine the effects of fish protein on insulin sensitivity in PCOS women with insulin resistance, and its mechanism of action on glucose and endocrine metabolism. Our working hypothesis is that dietary fish protein improves insulin sensitivity, glucose tolerance, and related plasma endocrine and lipid abnormalities in PCOS women by restoring secretory β-cell function and insulin signaling to the PI 3-kinase activity/Akt pathway. We further hypothesize that fish protein will improve cycle regularity and ovarian function.

NCT ID: NCT01738763 Completed - Healthy Clinical Trials

Effects of Different Doses of Pinitol on Carbohydrate Metabolism Parameters in Healthy Subjects

Start date: July 2011
Phase: N/A
Study type: Interventional

The purpose of this study was to assess the acute effects of increasing doses of pinitol on glucose tolerance and insulin sensitivity and to evaluate the absorption of pinitol after consumption of an oral nutritive pinitol-enriched beverage in healthy subjects.

NCT ID: NCT01736202 Completed - Insulin Sensitivity Clinical Trials

Acute Effects of an Oral Fat Load on Skeletal Muscle and Hepatic Insulin Sensitivity

FLAME
Start date: March 2012
Phase: Phase 4
Study type: Interventional

The development of type 2 diabetes is based on a combination of insulin resistance and beta cell dysfunction. In the last years, elevated FFA were recognized as a key players in the pathogenesis of insulin resistance and type 2 diabetes. The study compares the acute effects of an oral lipid bolus on insulin sensitivity and hepatic glucose metabolism in healthy humans.